Trials / Completed
CompletedNCT02751411
Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months
Multicenter, Prospective, Comparative, Randomized Controlled Clinical Trial to Evaluate the Performance and the Safety of Promelaxin® Micro-enemas Vs. Macrogol 4000 Per os in the Treatment of Functional Chronic Constipation in Children Aged Between 6 and 48 Months.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- Aboca Spa Societa' Agricola · Industry
- Sex
- All
- Age
- 6 Months – 48 Months
- Healthy volunteers
- Not accepted
Summary
The study is aimed at the efficacy and safety evalutation of the study treatments through a 2-weeks study period and the subsequent follow-up-
Detailed description
This multicenter, prospective, randomized, controlled trial will be conducted on 120 infants-children with a diagnosis of chronic functional constipation according to the definition of Criteria of Rome III. The enrolled subjects will be randomized according to an electronically generated randomization list in 2 groups: one group will receive micro-enemas of Promelaxin® (Group A) while the second group will receive Macrogol 4000 per os (Group B) . Children will receive the dedicated treatment for two weeks and then undergo a follow-up period of a maximun of 6 weeks. The hypothesis is that the protective micro-enema will help achieving regular evacuation by its local antinflammatory non-pharmacological action. This hypothesis is based on the finding that local anal inflammation can cause functional constipation due to discomfort and pain during evacuation or by influencing reflexes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | micro-enema with Promelaxin | The intervention has a lubricating, protective action on the anus and rectum and a balanced osmotic action which elicits the evacuation reflex. |
| DRUG | Macrogol 4000 | Stool softener |
Timeline
- Start date
- 2016-04-18
- Primary completion
- 2019-12-31
- Completion
- 2020-03-17
- First posted
- 2016-04-26
- Last updated
- 2020-05-29
Locations
4 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT02751411. Inclusion in this directory is not an endorsement.